ArticleOncology letters2024

Doxazosin inhibits vasculogenic mimicry in human non‑small cell lung cancer through inhibition of the VEGF‑A/VE‑cadherin/mTOR/MMP pathway.

Jui-Ling Hsu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.